No abstract available
MeSH terms
-
Antipsychotic Agents* / adverse effects
-
Antipsychotic Agents* / economics
-
Antipsychotic Agents* / therapeutic use
-
Benzodiazepines / adverse effects
-
Benzodiazepines / therapeutic use
-
Clinical Trials as Topic
-
Clozapine / adverse effects
-
Clozapine / therapeutic use
-
Drug Costs
-
Evidence-Based Medicine
-
Glucose Intolerance / chemically induced
-
Haloperidol / adverse effects
-
Haloperidol / therapeutic use
-
Humans
-
Lipids / blood
-
Olanzapine
-
Perphenazine / adverse effects
-
Perphenazine / therapeutic use
-
Practice Guidelines as Topic
-
Risk Factors
-
Risperidone / adverse effects
-
Risperidone / therapeutic use
-
Schizophrenia / drug therapy
-
Selective Serotonin Reuptake Inhibitors* / adverse effects
-
Selective Serotonin Reuptake Inhibitors* / economics
-
Selective Serotonin Reuptake Inhibitors* / therapeutic use
-
Weight Gain / drug effects
Substances
-
Antipsychotic Agents
-
Lipids
-
Serotonin Uptake Inhibitors
-
Benzodiazepines
-
Perphenazine
-
Clozapine
-
Haloperidol
-
Risperidone
-
Olanzapine